VIGL

VIGL

USD

Vigil Neuroscience Inc. Common Stock

$1.790+0.000 (0.000%)

Prix en Temps Réel

Healthcare
Biotechnologie
États-Unis

Graphique des Prix

Métriques Clés

Métriques de Marché
Fondamentaux de l'Entreprise
Statistiques de Trading

Métriques de Marché

Ouverture

$1.790

Haut

$1.820

Bas

$1.745

Volume

0.00M

Fondamentaux de l'Entreprise

Capitalisation Boursière

83.5M

Industrie

Biotechnologie

Pays

United States

Statistiques de Trading

Volume Moyen

0.24M

Bourse

NMS

Devise

USD

Intervalle sur 52 Semaines

Bas $1.312Actuel $1.790Haut $6.06

Actualités Connexes

Analyst Upgrades

Wedbush Maintains Outperform on Vigil Neuroscience, Lowers Price Target to $13

Wedbush analyst Laura Chico maintains Vigil Neuroscience with a Outperform and lowers the price target from $24 to $13.

Voir plus
Wedbush Maintains Outperform on Vigil Neuroscience, Lowers Price Target to $13
Analyst Upgrades

HC Wainwright & Co. Maintains Buy on Vigil Neuroscience, Lowers Price Target to $14

HC Wainwright & Co. analyst Andrew Fein maintains Vigil Neuroscience with a Buy and lowers the price target from $17 to $14.

Voir plus
HC Wainwright & Co. Maintains Buy on Vigil Neuroscience, Lowers Price Target to $14
GlobeNewswire

Vigil Neuroscience Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Recent Business Updates

– Announced positive data from Phase 1 clinical trial evaluating VG-3927 for potential treatment of Alzheimer's Disease (AD); plans to initiate Phase 2 clinical trial in Q3 2025 – – On track to report final analysis

Voir plus
Vigil Neuroscience Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Recent Business Updates